Schedule
of Supplemental Disclosure of Cash Flow Information
|
|
2021 |
|
|
2020 |
|
|
|
Six Months Ended June 30, |
|
|
|
2021 |
|
|
2020 |
|
Cash paid for interest |
|
$ |
- |
|
|
$ |
9,455 |
|
Cash paid for income taxes |
|
$ |
281,025 |
|
|
$ |
- |
|
|
|
|
|
|
|
|
|
|
Non-cash investing and financing activities: |
|
|
|
|
|
|
|
|
Preferred stock of VisualMED received from the sale of HTS and AMSG |
|
$ |
8,500,000 |
|
|
$ |
- |
|
Net liabilities of HTS and AMSG transferred to VisualMED |
|
|
2,227,152 |
|
|
|
- |
|
Series I-2 Preferred Stock converted into common stock |
|
|
- |
|
|
|
25,000 |
|
Exchange of Series K Preferred Stock for Series L Preferred Stock |
|
|
- |
|
|
|
(2,500 |
) |
Issuance of Series L Preferred Stock |
|
|
- |
|
|
|
2,500 |
|
Issuance of Series M Preferred Stock in exchange for related party loans and accrued interest |
|
|
- |
|
|
|
22,000,000 |
|
Loans and accrued interest exchanged for Series M Preferred Stock |
|
|
- |
|
|
|
18,849,632 |
|
Deemed dividend from exchange of loans and accrued interest for Series M Preferred Stock |
|
|
- |
|
|
|
3,150,368 |
|
Series M Preferred Stock converted into common stock |
|
|
619,650 |
|
|
|
- |
|
Series N Preferred Stock converted into common stock |
|
|
13,065,527 |
|
|
|
- |
|
Deemed dividends for trigger of down round provisions |
|
|
149,611,479 |
|
|
|
- |
|
Original issue discounts on debt |
|
|
27,630 |
|
|
|
63,695 |
|
|